Beauty Skin Corp. (406820) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Beauty Skin Corp. stock KRW 758, price KRW 1,600, that is 52.6% below the price, quality 29 out of 100. Rating: strongly overvalued. Calculated from audited financials with 5 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.
How to read this chart
39‑month range 1,560 KRW – 8,150 KRW · fair‑value band 660.08 KRW – 848.31 KRW · the 1,600 KRW price screens above the 757.64 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.
Follow Beauty Skin in your weekly email
Every Wednesday you see whether Beauty Skin is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Beauty Skin Corp. manufactures, markets, and distributes cosmetics in South Korea. It offers foundation, hair, body, mask packs, skincare, hue, cleansing foam, hand cream, and gifting products. The company was founded in 2005 and is headquartered in Seoul, South Korea.
Stock analysis
Beauty Skin Corp. (406820) currently trades at 1,600 KRW, while our model-based Fair Value estimate is 757.64 KRW, 53% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of 1,604 KRW per share, and 1 of the 5 models we run sit above the 1,600 KRW price.
Bear case: the DCF Models group reads lowest at 891.34 KRW, and 4 of the 5 models stay below the price. Data coverage for this calculation is low.
Scenario range: 660.08 KRW (bear) to 848.31 KRW (bull), the price of 1,600 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 29/100 (below-average quality), in the Consumer Defensive sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Beauty Skin Corp. reported revenue of 54.9B KRW in FY2025 versus 41.2B KRW in FY2021, a compound +7.5%/yr. Reported net income was −1.7B KRW in FY2025.
Key figures
Market cap 22.4B KRW (≈ $16.4M) Micro · P/S ratio 0.48 · EPS (TTM) −208.14 KRW · Net margin −3.1% · Return on equity −11.0% · Return on assets (EBIT) −1.5% (5-year average) · Operating margin 2.4% · Revenue (TTM) 51.7B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 16 out of 100 (medium confidence).
What moves the price
The share trades about 77% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −26% fair-value upside, at −53%, 406820 screens richer than that median.
Fair Value models
Bear660.08 KRWFair Value 757.64 KRWBull848.31 KRW
Price 1,600 KRW · Downside -52.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF1,149 KRW1,577 KRW2,313 KRW77
Growth DCF1,197 KRW1,604 KRW2,253 KRW76
5Y Revenue Exit523.38 KRW650.51 KRW831.79 KRW71
All 5 models by family
DCF Models
FCF DCF1,149 KRW1,577 KRW2,313 KRW77
5Y Revenue Exit523.38 KRW650.51 KRW831.79 KRW71
10Y Revenue Exit776.57 KRW891.34 KRW998.01 KRW65
Asset-Based
NCAV (Graham)868.58 KRW1,164 KRW1,737 KRW54
Growth DCF
Growth DCF1,197 KRW1,604 KRW2,253 KRW76
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.18/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−32.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.3%
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
7.8% (2021) → −5.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+47.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +44.2% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 230 stocks
Beats the industry median on 3/10 measures
Overall it trails its industry peers.
Valuation
Quality Score29 · Bottom 25%
Fair Value upside−52.6% · Bottom 25%
Profitability
Return on assets−2.0% · Bottom 25%
Net margin (12 months)−5.7% · Bottom 25%
Operating margin (12 months)2.4% · Below median
Growth and dividend
Revenue growth (quarter YoY)20.1% · Top 25%
Balance sheet
Debt / equity0.30× · Highest 25%
Valuation Multiplesvs Household & Personal Products median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Beauty Skin Corp. (406820) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of 757.64 KRW versus a price of 1,600 KRW, about 53% lower (overvalued).
What is the fair value of 406820?
Our model-based fair value for Beauty Skin Corp. is 757.64 KRW (as of Nov 4, 2026), built from audited fundamentals. The current price: 1,600 KRW.
What is the quality score of 406820?
Beauty Skin Corp. has a Quality Score of 29/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Beauty Skin Corp. (406820)?
Our model-based price target is the fair value of 757.64 KRW (as of Nov 4, 2026) from 5 valuation models. Cautious scenario 660.08 KRW, optimistic scenario 848.31 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Beauty Skin Corp. stock forecast for 2026?
Our models put fair value at 757.64 KRW, about 53% lower versus a price of 1,600 KRW (overvalued). Cautious scenario 660.08 KRW, optimistic scenario 848.31 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Beauty Skin Corp. (406820)?
Beauty Skin Corp. reported trailing-twelve-month revenue of about 51.7B KRW (latest available figure, as of Nov 4, 2026).
What growth is priced into Beauty Skin Corp. (406820)?
For today's price to be fair in a discounted-cash-flow model, Beauty Skin Corp. would have to grow free cash flow by +47.2 % per year for five years (discount rate 10.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 4 years revenue grew +7.5 % per year. As of Nov 4, 2026.
What discount rate (WACC) does the fair value of 406820 use?
Our models discount Beauty Skin Corp. at 10.3 %: a base by market capitalisation (nano), damped by beta 1.06, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Beauty Skin Corp. that is +47.2 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.3 %) and the same formula as our fair value.
How much growth has Beauty Skin Corp. (406820) delivered so far?
Over the past 4 years revenue at Beauty Skin Corp. grew +7.5 % a year. The price currently implies free-cash-flow growth of +47.2 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Beauty Skin Corp. (406820) growing?
The median revenue growth in the sector is +2.0 % a year. That is the yardstick for the growth priced into Beauty Skin Corp. (+47.2 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Beauty Skin Corp. (406820)?
The free-cash-flow yield on the price is 1.65 %: that much free cash flow Beauty Skin Corp. produces per unit of market value. When it exceeds the discount rate of our models (10.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Beauty Skin Corp. (406820)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Beauty Skin Corp. it is 757.64 KRW per share (as of Nov 4, 2026), against a price of 1,600 KRW. It is the blended result of 5 valuation models in 3 families (DCF Models, Asset-Based, Growth DCF).
Is Beauty Skin Corp. stock overvalued or undervalued in 2026?
As of Nov 4, 2026, 406820 trades above its calculated fair value: price 1,600 KRW, fair value 757.64 KRW, a gap of about −53% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 406820?
No. The price is what the market pays today (1,600 KRW); the fair value is what the company's own numbers justify (757.64 KRW). For Beauty Skin Corp. the two are 842.36 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Beauty Skin Corp. worth?
The market values Beauty Skin Corp. at about 22.4B KRW (market capitalisation, as of Nov 4, 2026). Per share that is 1,600 KRW; our models calculate a fair value of 757.64 KRW per share.
What do the bullish and bearish scenarios say about 406820?
Our models span a range for Beauty Skin Corp.: cautious scenario 660.08 KRW, base 757.64 KRW, optimistic 848.31 KRW per share (as of Nov 4, 2026, price 1,600 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Beauty Skin Corp. (406820)?
Balance-sheet figures for Beauty Skin Corp. (as of Nov 4, 2026): return on equity −11.0%, debt of 0.30 per unit of equity. They feed the Quality Score of 29/100, which measures business quality independently of the share price.
How far is 406820 from its 52-week high?
Beauty Skin Corp. trades at 1,600 KRW, about 77% below its 52-week high of 6,850 KRW and 3% above the low of 1,560 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 757.64 KRW is for.
Which stocks are comparable to Beauty Skin Corp.?
From the same area (Consumer Defensive) we also value Colgate-Palmolive Company, Hindustan Unilever Limited, The Estée Lauder Companies Inc, Henkel AG, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Beauty Skin Corp. stock attractive at the current price?
The data as of Nov 4, 2026: price 1,600 KRW, calculated fair value 757.64 KRW (−53%), Quality Score 29/100, from 5 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 406820 calculated?
We run Beauty Skin Corp. through 5 models from 3 families: DCF Models, Asset-Based, Growth DCF. Every model gets the same audited fundamentals; the fair value of 757.64 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Beauty Skin Corp. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Beauty Skin Corp. (406820)?
The closing price on Nov 6, 2026 was 1,600 KRW. Our model-based fair value is 757.64 KRW, about 53% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Beauty Skin Corp. right now?
The price sits above even our optimistic bull case (848.31 KRW). The favourable scenario is already priced in. Weak quality (29/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Beauty Skin Corp.
How large is the market capitalisation of Beauty Skin Corp. (406820)?
The market capitalisation of Beauty Skin Corp. is 22.4B KRW (≈ $16.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Beauty Skin Corp. (406820)?
The price-to-sales ratio of Beauty Skin Corp. is 0.48 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Beauty Skin Corp. (406820)?
Earnings per share at Beauty Skin Corp. are −208.14 KRW. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Beauty Skin Corp. (406820)?
The net margin of Beauty Skin Corp. is −3.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Beauty Skin Corp. (406820)?
The return on equity (ROE) of Beauty Skin Corp. is −11.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Beauty Skin Corp. (406820)?
On an EBIT basis the return on assets of Beauty Skin Corp. is −1.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Beauty Skin Corp. (406820)?
The operating margin of Beauty Skin Corp. is 2.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Beauty Skin Corp. (406820)?
Revenue at Beauty Skin Corp. is growing +20.1% versus a year earlier (3y avg −2.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Beauty Skin Corp. (406820)?
Earnings per share at Beauty Skin Corp. are growing +635% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Beauty Skin Corp. (406820) carry?
The net debt of Beauty Skin Corp. is 29.0B KRW (fiscal year 2025, ≈ 80.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Beauty Skin Corp. in the live analysis
One click puts Beauty Skin Corp. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 4, 2026